Back

Do we need antiplatelet therapy before transcatheter aortic valve implantation?

27 August 2016 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster session 1 - Aortic valve disease Surgery and intervention in valve disease ESC Premium Access ESC Congress 2016

About the speaker

Photo
Doctor Hirofumi Hioki

Teikyo University Hospital, Tokyo (Japan)

28 More presentations in this session

Presentation thumbnail
Aortic valve gradient and mortality in patients undergoing transcatheter aortic valve implantation for severe aortic stenosis
Doctor G. Witberg (Petah Tikva, IL)
Presentation thumbnail
Postprocedural pacemaker rate is related to implantation depth and calcium distribution pattern after Sapien 3 implantation
Doctor V. Mauri (Cologne, DE)
Abstract
Presentation thumbnail
Endothelial and platelet derived microparticles in patients undergoing transcatheter aortic valve implantation (TAVI)
Doctor B. Wernly (Salzburg, AT)
Abstract Slides
Presentation thumbnail
The impact of the development of TAVI on the management of severe aortic stenosis in high-risk patients: treatment strategies and outcome.
Professor C. Bouleti (Poitiers, FR)
Abstract Slides
Presentation thumbnail
Treatment options in intermediate-high risk patients with aortic stenosis and renal disfunction: the european multicenter propensity match study comparing tavr versus conventional avr surgery
Professor C. Muneretto (Brescia, IT)
Abstract Slides

Access the full session

Session thumbnail
Poster session 1 - Aortic valve disease

The Event

Event poster

ESC Congress 2016

27 August - 31 August 2016

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources